Raymond James Financial
MEDS

Raymond James Financial’s DataMeds AI, Inc. Common Stock MEDS Stock Holding History

Raymond James Financial’s Portfolio MEDS Stock Details MEDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.63K Hold
1,168
– – ﹤0.01% 5269
2025
Q4 		$23.3K Hold
1,168
– – ﹤0.01% 5077
2025
Q3 		$51.8K Buy
1,168
+1,000
+595% +$52.8K ﹤0.01% 4819
2025
Q2 		$8.16K Buy
+168
New +$23.2K ﹤0.01% 6001

Other funds holding MEDS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
AA
ACT Advisors Asheville, North Carolina $301M AUM 23.36% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VFIC
Valley Forge Investment Consultants Audubon, Pennsylvania $334M AUM 17.84% 1-Year Est. Return

Raymond James Financial's MEDS Position: Q1 2026 in Review

Raymond James Financial held its DataMeds AI, Inc. Common Stock (MEDS) position steady in Q1 2026 at 1,168 shares worth $5.63K. The position accounts for ﹤0.01% of the portfolio, ranked #5269.

Raymond James Financial first reported a position in MEDS in Q2 2025 and has held it in 4 quarters since. The position peaked at $51.8K in Q3 2025. 13 funds tracked by Wall St. Rank hold MEDS as of Q1 2026.

  • Raymond James Financial held 1,168 shares of DataMeds AI, Inc. Common Stock worth $5.63K as of Q1 2026.
  • Raymond James Financial left its DataMeds AI, Inc. Common Stock share count unchanged in Q1 2026.
  • DataMeds AI, Inc. Common Stock made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #5269 holding.
  • Raymond James Financial first reported a position in DataMeds AI, Inc. Common Stock in Q2 2025 and has held it in 4 quarters since.
  • Raymond James Financial's DataMeds AI, Inc. Common Stock position peaked at $51.8K in Q3 2025.
  • 13 funds tracked by Wall St. Rank held DataMeds AI, Inc. Common Stock as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.